Skincare distribution company AestheticSource has announced the launch of Revision Skincare CMT Post-Procedure Cream.
The company explains that the product contains a patent-pending neurocosmetic technology which targets skin-brain communication to aid recovery after peels, microneedling and laser treatments. The technology suppresses receptors such as TRPV1, which send discomfort signals to the brain if they detect heat or distress, thus reducing post-procedure pain.
Revision Skincare says the product also contains pre- and post-biotics, ceramides and THD ascorbate to restore skin biome health, minimise moisture loss and reduce downtime.
Lorna Bowes, CEO at AestheticSource, said, “With clinically proven results to help the skin recover better and faster, CMT Post-Procedure Cream improves the overall treatment experience whilst also increasing the likelihood of completing the recommended number of treatments. With the CMT standing for its post-healing for chemical, mechanical and thermal procedures, it makes for a pioneering addition to the Revision Skincare lineup.”
